FDA will limit the use of GlaxoSmithKline and Vir's COVID-19 antibody treatment in some ...

Retrieved on: 2022-02-24 22:28:05

Tags for this article:

Click the tags to see associated articles and topics

FDA will limit the use of GlaxoSmithKline and Vir's COVID-19 antibody treatment in some .... View article details on hiswai:

Excerpt

When it comes to combating mild to moderate cases of COVID-19, oral antivirals are gaining favor while monoclonal antibody treatments are fading ...

Article found on: www.fiercepharma.com